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Abstract 
A series composed of a tetra-, a tris- and a bisphosphonated ligand based on a pyridine scaffold 
(L
4
, L
3
 and L
2
, respectively) was studied within the frame of lanthanide (Ln) coordination. The stability 
constants of the complexes formed with lanthanide cations (Ln=La, Nd, Eu, Gd, Tb, Er and Lu) were 
determined by potentiometry in aqueous solutions (25.0 °C, 0.1 M NaClO4), showing that the 
tetraphosphonated complexes are among the most stable Ln
III
 complexes reported in the literature. The 
complexation of L
4
 was further studied by different titration experiments using mass spectrometry and 
various spectroscopic techniques including UV/Vis absorption, and steady state and time-resolved 
luminescence (Ln=Eu and Tb). Titration experiments confirmed the formation of highly stable [LnL
4
] 
complexes. 
31
P NMR experiments of the LuL
4
 complex revealed an intramolecular interconversion process 
 
 
which was studied at different temperatures and was rationalized by DFT modelling. The relaxivity 
properties of the Gd
III
 complexes were studied by recording their 
1
H NMRD profiles at various temperatures, 
by temperature dependent 
17
O NMR experiments (GdL
4
) and by pH dependent relaxivity measurements at 
0.47 T (GdL
3
 and GdL
2
). In addition to the high relaxivity values observed for all complexes, the results 
showed an important second-sphere contribution to relaxivity and pH dependent variations associated with 
the formation of aggregates for GdL
2
 and GdL
3
. Finally, intravenous injection of GdL
4
 to a mouse was 
followed by dynamic MRI imaging at 1.5 T, which showed that the complex can be immediately found in 
the blood stream and rapidly eliminated through the liver and in large part through the kidneys. 
Keywords: imaging agents; lanthanide; luminescence; phosphonate; relaxivity 
 
Introduction 
Magnetic resonance imaging (MRI) has become an inescapable tool in the clinical diagnostic toolbox, 
providing exquisite images of soft tissues with a large range of contrast. This success is in part due to the 
large improvements brought by contrast agents, and in particular those based on gadolinium 
complexes.
[1] 
The more or less close contact of water molecules with the paramagnetic Gd
III
 centers results in 
an important shortening of the longitudinal (T1) and transverse (T2) relaxation times of the proton nuclei of 
water molecules. Even if numerous contrast agents are currently used in clinical practice, there is still a large 
number of reports on new Gd
III
 complexes aiming at improving the basic relaxivity properties of the probes 
or targeting specific applications with the use of “smart” contrast agents.[2] Among those, there is a growing 
interest in phosphonated complexes,
[3]
 as the introduction of these functions or the replacement of carboxylic 
acid by phosphonic ones have proved to play a significant role on the relaxivity of Gd
III
 complexes.
[4]
 
First, phosphonic acid possesses two dissociation constants, the second one being generally slightly below 
neutral pH.
[5]
 Phosphonate functions are found to be twice negatively charged near the biological window, 
allowing for strong electrostatic interactions with metal cations in general
[6]
 and lanthanide ions in 
particular.
[7]
 As a second point, it has been noticed that the basicity of the amines of phosphonated analogues 
of amino acids is increased by the presence of the phosphonate function,
[8] 
with a concomitant increase of the 
stability of the complexes formed with cations.
[5] 
A third important aspect in the comparison of phosphonate 
and carboxylate functions is the larger steric hindrance brought by the former. A typical example is the 
comparison of the Gd
III
 complexes of DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakisacetic acid) 
and its phosphonated analogue DOTP. While the numerous studies on [Gd(DOTA)] complexes showed its 
coordination sphere to be completed by the presence of one water molecule,
[9] 
those on 
[Gd(DOTP)]
[10] 
confirmed the absence of this supplementary coordination due to the bulkier substituents. 
These results are in line with other studies showing that the hydration numbers of Gd
III
 complexes decreased 
by one unit when more than one carboxylate functions are replaced by phosphonate ones.
[11]
 Finally, 
phosphonate functions induce large second-sphere interactions with water molecules or cations in 
solution.
[12]
 
Within the frame of our search for highly efficient complexes for molecular imaging, we have been 
interested in the design of polyphosphonated chelates for luminescence,
[7, 13] 
or radiochemical 
applications.
[14] 
In this study, we report on the coordination behavior of a series of bis-, tris- and 
tetraphosphonated ligands (Scheme 1) with lanthanide cations and we particularly inspect the influence of 
the number of phosphonic coordinating units on the relaxation properties of the corresponding Gd
III
 chelates. 
 
 
 
 
 
Scheme 1. Molecular structures of ligands L
2
 to L
4
 with numbering Scheme used for 
1
H NMR  
spectral assignment of L
4
. 
 
 
Results and discussion 
In order to get insight into the complexation behavior of the ligands with lanthanide cations, we first 
recorded some titration experiments in which the evolution of the absorption and emission spectra of the 
ligands were monitored as a function of added cations into the solutions. As an example, the titration of 
ligand L
4
 by Tb
III
 is depicted in Figure 1. 
From 0 to one equivalent of added Tb, both absorption and emission spectral changes showed monotonous 
variations attributed to the formation of a first species with a one to one metal to ligand ratio. The 
fluorescence titration revealed a typical behavior associated with the coordination of Tb
III
 to the ligand, that 
translates into a Tb centered emission upon ligand excitation (λexc=265 nm), that is, an antenna 
effect.
[15]
 After one equivalent, the luminescence dropped, pointing to the formation of new species. A 
striking phenomenon was observed in the absorption titration for Ln/L
4
 (Ln=Eu and Tb) molar ratios 
between 2 and 2.5. The baseline of the spectra gradually drifted, indicating the formation of 
nano/microparticles that result in light scattering in the cell. The same observation could be made for Eu 
(Figure S1), with the same drift for ratios between 2 and 2.5. 
The composition of the LnL
4
 complexes (Ln=Eu
III
 and Tb
III
) was further confirmed in solution by recording 
the ES/MS spectra of solutions containing equimolar amounts of the cations and ligand in water (Figures S2 
and S3). For both complexes, the major species detected corresponded to a [LnL
4
] composition, as evidenced 
by the isotopic distribution observed for the Eu
III
 complex with the presence of 
151
Eu and 
153
Eu isotopes. The 
luminescence properties (excited state lifetime and luminescence quantum yield) of equimolar solutions of 
the ligands with Eu or Tb were determined in water and deuterated water and the results are gathered in 
Table 1. 
It is to be noticed that the reported lifetimes have to be taken as indicative values calculated from mono-
exponential fits of the data, despite the evidences that point to the presence of mixtures of complexes with 
different lifetimes, probably resulting from the complex acid–base equilibria present in solution (see below). 
It is thus not surprising that the calculated hydration numbers, that is, the number of water molecules directly 
coordinated to the Ln
III
 cations, are rarely integer values. The overall luminescence quantum yields of this 
family of complexes are modest to poor and always one order of magnitude better for Tb than for Eu, as 
generally observed for pyridine based lanthanide complexes.
[17]
 
 
 
 
Figure 1. Top: Evolution of the absorption spectra of a solution of L
4
 (c=8.5×10
−5 M, 0.01 M TRIS/HCl, pH 7.0) upon 
addition of TbCl3⋅6H2O (inset: evolution of the absorbance at 265 nm). Bottom: Evolution of the emission spectra of the 
same solutions (λexc=265 nm, inset: evolution of the emission intensity at 545 nm). 
 
 
Table 1. Spectroscopic properties of equimolar mixtures of ligands and Eu or Tb in water and heavy water. 
 𝝉𝐇𝟐𝐎 [𝐦𝐬]  𝝉𝐃𝟐𝐎 [𝐦𝐬] 𝝓𝐇𝟐𝐎 (× 𝟏𝟎𝟎) q
[a]
 
EuL
2
 0.364 1.43 0.02 2.2 
TbL
2
 1.17 2.40 0.36 1.9 
EuL
3
 0.35 1.07 0.036 2.0 
TbL
3
 0.93 1.34 0.32 1.3 
EuL
4
 0.57 2.21 0.12 1.3 
TbL
4
 1.52 2.90 10.6 1.3 
 
[a] Calculated according to reference [16], estimated error ±15 %. 
 
 
Considering the prior evidence of the formation of a one to one metal to ligand complex, the thermodynamic 
stability constants for the formation of lanthanide complexes with ligands L
2
 to L
4
were determined by 
potentiometry for equimolar concentrations of lanthanide salts and of the ligands using the values of the 
 
 
protonation constants previously determined for L
2
 to L
4
,
[18]
 and taking from the literature the values for the 
hydrolysis constants of the lanthanide ions.
[19]
 
Table 2 summarizes the newly determined stability constants obtained for L
2
 and L
3
, together with those 
previously reported for L
4
.
[4b] 
When possible, the protonation constants of the complexes were also 
determined. 
 
Table 2. Thermodynamic stability constants and protonation constants for the complexes formed with 
ligands L
2
 to L
4
 and various Ln
III
 cations along the series and corresponding values of pLn.
[a] 
 
 La Nd Eu Gd Tb Er Lu 
log 𝐾ML4
[b]
 25.5(4) 27.1(3) 25.7(3) – 29.7(6) 29.7(1) 29.3(4) 
log 𝐾ML4H
[b]
 9.4(4) 8.8(3) 9.4(3) – 7.6(7) 7.8(1) 7.4(6) 
log 𝐾ML4H2
[b]
 7.3(6) 6.6(4) 7.5(4) – 
[c] [c]
 
[c]
 
log 𝐾ML3  16.3(1) 16.8(1) – 16.95(9) – 16.8(1) 
[c]
 
log 𝐾ML3H 8.0(2) 7.9(2) – nd – nd 
[c]
 
log 𝐾ML3H2  7.6(2) 7.4(2) – nd – nd 
[c]
 
log 𝛽ML3H2  15.6(3) 15.3(3) – 14.6(1)   14.7(2)   
log 𝐾ML3H3  4.7(2) 4.7(2) – 4.5(1) – 4.8(3) 
[c]
 
log 𝐾ML2  10.14(4) 10.66(5) – 11.22(5) – 11.15(3) 
[c]
 
log 𝐾ML2H 9.19(5) 9.35(6) – 9.16(6) – 9.25(4) 
[c]
 
log 𝐾ML2H2  7.42(5) 7.40(6) – 7.21(6) – 7.90(4) 
[c]
 
pLnL4  20.6 21.3 20.9 – 22.6 22.7 21.9 
pLnL3  11.3 11.4 – 10.6 – 10.8 
[c]
 
pLnL2  7.3 8.0 – 8.2 – 8.3 
[c]
 
pLnDOTA
[20]
 17.8 17.8 18.4 19.6 19.6 19.6 20.3 
pLnDOTP
[21]
 21.5 21.2 21.5 22.5 22.6 24.3 24.3 
        
[a] pLn values are defined by pLn=−log[LnIII]free at pH 7.0 for [Ln
III
]=1 μM and [L]=10 μM.[22]  
[b] According to reference [4b].  
[c] Precipitation of the complexes precludes accurate determination. The hydrolysis constants of the free 
Ln
3+
cations have been taken into account in the statistical processing (logKLaOH=−8.83; logKNdOH=−8.20; 
logKEuOH=−7.78; logKGdOH=−7.85; logKTbOH=−7.66; logKErOH=−7.54; logKLuOH=−7.29). n.d.=not 
determined with good accuracy (only the global constant was determined and is given due to the close 
values of 𝐾ML3H and 𝐾ML3H2. 
 
 
As anticipated for acyclic chelators, the increase of the binding constants follows a monotonous trend 
(Figure 2 and Table 2) with the increasing number of phosphonates borne by the ligand. As it was previously 
noted, the stability of the complexes formed with L
4
 is very high, almost as stable as the complexes formed 
with DOTP. In contrast, the loss of a single phosphonate function resulted in a dramatic decrease of the 
stability constant (or pLn) values for ligand L
3
, the values dropping of more than ten log units (Figure 2). 
The loss of a second phosphonate function leading to L
2
 also resulted in a drop of the stability, but the 
amplitude of this decrease is far less important (Table 2). Further loss of phosphonate unit would lead to 
weak chelator (pLn ∼6) as exemplified by the stability constants measured for a related system lacking 
phosphonate moieties (cy2PYAN, logKLLa=2.1 and logKLGd=5.6 and logKLLu=6).
[23]
 
 
 
 
 
Figure 2. pLn
III
 values for La
III
 (square), Nd
III
 (circle) and Er
III
 (triangles) complexes as a function of the number of 
phosphonates borne by L
2
, L
3
 and L
4
. 
 
Solution structure and dynamics of LnL
4
 complexes 
The solution 
1
H, 
13
C and 
31
P NMR spectra of the diamagnetic LaL
4
 and LuL
4
 complexes were recorded in 
D2O solution at pD 10.9. At this pD, the predominant species in solution is expected to be the fully 
deprotonated form, as demonstrated by potentiometric measurements (see above). The 
1
H NMR spectrum of 
the La
III
 complex recorded at 298 K shows only five signals (Figure 3), which suggests an 
effective C2v symmetry of the complex in solution. This is confirmed by the 
13
C spectrum, which consists of 
five signals for the 11 carbon nuclei of the ligand backbone. 
 
 
Figure 3. 
1
H NMR spectra of the La
III
 and Lu
III
 complexes of L
4
 recorded in D2O solution at  
different temperatures (pD 10.9); see Scheme 1 for H labelling. 
 
 
The 
13
C NMR resonance due to the methylenephosphonate groups is split into a doublet of doublets by spin 
coupling to the adjacent phosphorous (
1
JPC=143.1 Hz) and to that three bonds away (
3
JPC=8.9 Hz). Similar 
coupling constants have been previously observed for Ln
III
 complexes with ligands containing 
methylenephosphonate groups.
[24,31] 
The 
31
P NMR spectrum shows a single resonance at 19.9 ppm, which 
confirms an effective C2v symmetry of the complex in solution with the four methylenephosphonate groups 
of the ligand being equivalent. The assignments of the proton signals are given in Table S1 (Supporting 
Information). The 
1
H NMR signal due to H4 is observed as a singlet, while the protons of the 
methylenephosphonate groups give two multiplets consistent with an ABX spectrum (where X is the 
31
P 
nucleus). Thus, the geminal proton nuclei of methylenephosphonate groups are not equivalent. 
The proton spectrum of LuL
4
 recorded at 298 K (Figure 3) shows broad signals for the methylene groups, 
indicating the presence of intramolecular dynamic exchange processes in solution. The spectrum recorded at 
278 K exhibits a better resolution, as pointed out in our previous communication,
[4c] 
and it is consistent with 
an effective C2 symmetry of the complex in solution (Table S1). This is confirmed by the 
31
P NMR spectrum 
recorded at 278 K, which shows two signals at 18.9 and 21.6 ppm (Figure 4). 
Above this temperature these two signals gradually broaden, and then coalesce at a temperature close to 323 
K. Thus, the 
1
H and 
31
P NMR spectra of LuL
4
 recorded at low temperature show different signals for the in-
plane and out-of-plane methylenephosphonate groups with respect to the average plane formed by the 
pyridine unit and the metal ion (Scheme 2). 
 
 
Scheme 2. In-plane (ip) and out-of-plane (op) methylenephosphonate groups in LnL
4
 complexes. 
 
DFT calculations provide 
31
P NMR chemical shifts of 16.1 and 13.5 ppm for the ip and op 
methylenephosphonate groups, respectively. These values compare reasonably well with the experimental 
ones (21.6 and 18.9 ppm, respectively), particularly taking into account the systematic deviations observed 
previously for calculated 
13
C NMR shifts obtained using similar methodologies.
[25] 
Thus, the 
31
P NMR signal 
due to ip groups is more deshielded than those corresponding to op ones, probably as a consequence of the 
deshielding effect of the pyridine ring current. Once the 
31
P NMR signals were assigned, a full assignment of 
the 
1
H NMR signals was obtained from the cross-peaks observed in the two-dimensional HMBC experiment, 
which gave strong cross peaks relating the 
31
P NMR signal at 21.6 ppm to the 
1
H signal at 2.93 ppm, and 
the 
31
P NMR signal at 18.9 ppm to the 
1
H signals at 2.19 and 2.90 ppm. 
 
 
 
Figure 4. Top: 
31
P-{H} NMR spectra of LuL
4
 recorded in D2O solution at different temperatures (pD 10.9);  
see Scheme 1 for H labeling. Bottom: Eyring plot for the Δ↔Λ enantiomerization in LuL4 based  
upon line-broadening data. 
 
The 
1
H and 
31
P spectra of LuL
4
 reflect the occurrence in solution of a conformational exchange process that 
can be attributed to a rotation of the methylenephosphonate groups leading to the Δ↔Λ enantiomerization 
mechanism previously observed with tetracarboxylated chelates.
[26] 
The rotation of the 
methylenephosphonate groups exchanges the in-plane and out-of-plane methylenephosphonate groups 
(Scheme 2). This process is fast on the 
31
P NMR time scale at room temperature in the case of the 
La
III
 complex, and slow in the case of the Lu
III
 analogue. Thus, there is an increasing rigidity of the 
complexes in solution on decreasing the ionic radius of the metal ion, as often observed for Ln
III
complexes 
due to the increased positive charge density of the lanthanide ion along the series.
[27] 
The 
1
H NMR spectra of 
the La
III
 complex indicate that the Δ↔Λ enantiomerization process occurs through an intramolecular 
 
 
mechanism that does not require the decoordination of methylenephosphonate groups, as such process would 
average the signals due to the geminal H5a and H5b protons. Indeed, the 
1
H NMR spectra of the La
III
 and 
Lu
III
 complexes shows that the Δ↔Λ interconversion leads to the exchange of protons H5a(ip)↔H5a(op) 
and H5b(ip)↔H5b(op). A similar intramolecular Δ↔Λ interconversion has been observed for different FeII, 
Ni
II
 and Zn
II
 EDTA and EDTA-like complexes.
[28]
 
A band-shape analysis was carried out on the 
31
P resonances of LuL
4
 over the 278–323 K temperature range 
in order to calculate the activation parameters for the Δ↔Λ interconversion process. 
An Eyring plot (R
2
> 0.995, Figure 4) of ln(k/T) versus 1/T [k=χ(kbT/h)exp(ΔS
#
/R−ΔH#/RT), where χis the 
transmission coefficient assumed to be 1, kb is the Boltzmann constant, T is the absolute temperature, k is the 
rate constant, and ΔG#, ΔH#, and ΔS# are the activation free energy, enthalpy, and entropy, respectively] 
yields the following activation parameters: ΔG#=68.7±10.2 kJ mol−1 at 298 K, ΔH#=81.9±3.3 kJ mol−1, and 
ΔS#=66.7±11.7 J K−1 mol−1. The positive activation entropy obtained for the Δ↔Λ racemization in [LuL4] is 
probably related to a reorganization of the second-sphere hydration shell around the negatively charged 
oxygen donor atoms in the transition state. Positive ΔS# values have been recently reported for the arm 
rotation process occurring in Ln
III–DOTA analogues with methylenephosphonate pendant arms.[29] 
Aiming to obtain information on the solution structure and dynamics of the LnL
4
 complexes, we performed 
density functional theory (DFT) calculations at the B3LYP level. Different studies have demonstrated that, 
due to their charge and important structure ordering effect, phosphonate groups have a tendency to induce a 
well-defined second hydration sphere around the metal complexes.
[12b, 30, 31]
 Thus, in our calculations we have 
taken into account solvent effects (water) by using a polarizable continuum model (PCM). Our previous 
calculations performed on the GdL
4
 complex
[4b]
 included a coordinated water molecule, in line with the 
relaxivity values and 
17
O NMR shifts obtained for this complex (see below), and with the luminescence 
lifetimes measured for the Eu
III
 and Tb
III
analogues. In the case of Lu
III
, the presence of a coordinated water 
molecule cannot be tested with any of these methods, but the smaller ionic radius of the metal ion might 
result in a q=0 complex. For this reason, and to simplify the computational study, we did not include an 
explicit water molecule in our LuL
4
 model system. 
The minimum energy conformation calculated for LuL
4
 is shown in Figure 5, while the bond lengths of the 
metal coordination environment are given in Table S2 (Supporting Information). According to our 
calculations the ligand provides an asymmetrical coordination of the metal ion, in contrast to the 
effective C2 symmetry of the complex observed by NMR. A close inspection of the optimized geometry of 
LuL
4
 shows that the asymmetrical coordination environment around Lu
III
 is due to a different orientation of 
the methylenephosphonate groups attached to one of the amine N atoms with respect to those bonded to the 
second one. 
Indeed, the conformation adopted by the ligand in this complex results in the occurrence of two helicities: 
one associated with the layout of the methylenephosphonate arms (absolute configuration Δ or Λ, and the 
other with the four five-membered chelate rings formed by the binding of the N-CH2-P-O units (each of them 
showing absolute configuration δ or λ).[32] The minimum energy conformation calculated for LuL4 
corresponds to the Δ(δλδλ) [or Λ(λδλδ)] form. The inversion of the two methylenephosphonate groups 
attached to one of the nitrogen atoms leads to a second energy minimum that shows an undistorted C2 
symmetry and corresponds to the Δ(δδδδ) [or Λ(λλλλ)] form. The calculated relative free energy of the 
Δ(δλδλ) conformation with respect to the Δ(δδδδ) one amounts to −10.3 kJ mol−1. According to our 
calculations the interconversion between the Δ(δλδλ) and Δ(δδδδ) forms of the LuIII complex is a one-step 
process involving the simultaneous inversion of two five-membered chelate rings (Figure 5). The free energy 
barrier associated with this process is relatively low, amounting only to 39.7 kJ mol−1. The inversion of two 
five-membered chelate rings of the Δ(δδδδ) conformation may occur through the rotation of the two 
methylenephosphonate groups attached to either of the amine N atoms of the ligand, providing either the 
 
 
starting Δ(δλδλ) form or the equivalent Δ(λδλδ) structure through transition states with identical energy (TS2 
and TS2′ in Figure 5). Thus, most likely the LuL4 complex adopts an asymmetrical Δ(δλδλ) [or Λ(λδλδ)] 
conformation in aqueous solution, a fast Δ(δλδλ) ↔ Δ(δδδδ) ↔ Δ(λδλδ) rearrangement being responsible for 
the effective C2 symmetry observed in the NMR spectra (C2-averaging in Figure 5). 
The transition state responsible for the Δ(δλδλ) ↔ Λ(λδλδ) enantiomerization process in LuL4 is shown in 
Figure 5 (TS1). This process requires an important deformation of the Lu
III
 coordination environment 
enforced by the simultaneous rotation of the four methylenephosphonate groups. In particular the Lu-N 
distances experience an important lengthening on going from the ground to the transition state (from ca. 2.74 
and 2.65 Å in the ground state to 2.82 Å in the TS). The calculated activation free energy for the 
Δ(δλδλ)↔Λ(λδλδ) interconversion process amounts to 71.9 kJ mol−1. This value is in excellent agreement 
with that obtained experimentally (68.7 kJ mol−1, see above), which supports that the mechanism predicted 
by our DFT calculations is basically correct. 
 
 
Figure 5. Relative free energies of minima, intermediates and transition states involved in the Δ(δλδλ) ↔ Δ(δδδδ) and 
Δ(λδλδ) ↔ Λ(δλδλ) interconversion processes of LuL4 in aqueous solution. 
 
1
H Relaxivity and 
17
O NMR Studies 
Relaxivity (r1p) represents the efficiency of the paramagnetic metal chelate in catalyzing the solvent nuclear 
magnetic relaxation at a given frequency and temperature, and it is defined as the increase of the water 
proton longitudinal relaxation rate (R1) value normalized to a 1 mM concentration of the metal ion. Figure 
6 represents the evolution of the relaxivity of the complexes as a function of the pH in water at 25 °C and 20 
MHz. The relaxivity of GdL
4
 measured at pH 10.5 (20 MHz and 298 K) increases smoothly from 7.7 to 8.9 
 
 
mM
−1 s−1 upon decreasing the pH at 6.5. In this pH range, extrapolation of the potentiometric data extracted 
for Eu (see Figure S4 for a distribution diagram of the [EuL
4
] species as a function of pH) suggests that none 
or a single phosphonate group of the ligand are protonated, and these different protonated states likely have a 
significant impact on some of the physicochemical parameters that control proton r1p. For instance, 
decreasing the negative electric charge of the complex is likely to induce a shortening of the distance 
between the Gd
III
 ion and proton nuclei of the coordinated water molecule, rGd−H, because of an increased 
electrostatic interaction between the coordinated water molecule and the metal ion. Below pH 
∼6.5, r1p suddenly increases reaching a value of 20.0 mM
−1 s−1 at pH 3.4. To unravel a possible change in 
hydration state of the complexes as a function of the pH, a titration was performed in which the excited state 
lifetime of the EuL
4
 complex (assumed to be isostructural to the GdL
4
 complex) was monitored as a function 
of the pH on water. The results (Table S3) did not indicate a drastic change of the hydration number within 
the pH range 2.7–11.5 and substantiate the hypothesis of aggregation phenomena as previously observed for 
other molecular Ln complexes.
[33] 
 
 
Figure 6. Plot of the relaxivity (20 MHz; 25 °C) measured for the GdIII complexes investigated in this work as a 
function of pH. The solid lines are simply a guide for the eye. 
 
The relaxivity of GdL
3
 increases steadily on decreasing the pH from 11.7 (r1p=10.6 mM
−1 s−1 at 20 MHz and 
298 K) to pH 2.0 (r1p=16.2 mM
−1 s−1). This can be explained by the gradual protonation of phosphonate 
groups on lowering the pH of the solution, which decreases the negative electric charge of the complex. As a 
result of the hexadentate nature of the ligand and the reduced negative charge of the complex, the Gd
III
 ions 
are coordinatively unsaturated. Thus, phosphonate groups can act as bridges between two Gd
III
 ions, 
resulting in the formation of [GdL
3
]n aggregates. 
The 
1
H NMRD profiles recorded for GdL
3
 at pH 6.47 and 8.05 confirm this hypothesis (Figure 7). They 
show a plateau at low field (0.01–1 MHz), where relaxivity receives a significant contribution from the 
electron spin relaxation time. Above about 1 MHz the relaxivity decreases, reaching a minimum at about 10 
MHz. Above 10 MHz r1p increases, giving rise to a broad peak around ∼70 MHz. Above about 10 MHz, the 
inner sphere contribution to r1p is largely determined by the residence lifetime of the inner-sphere water 
molecule(s) (τM) and the rotational correlation time (τR). The relaxivity increase observed in the region 10–60 
MHz is characteristic of systems with relatively long τR values. Furthermore, this relaxivity at 70 MHz is 
 
 
slightly higher at pH 6.47 than at pH 8.05, in line with a more extended aggregation of the [GdL
3
] complex 
upon lowering the pH of the solution. 
 
 
Figure 7. 
1
H NMRD profiles recorded for GdL
3
 at pH 6.47 (top) and 8.05 (bottom). 
 
The relaxivity of GdL
2
 at 20 MHz and 298 K also increases on lowering the pH from 12.0 (r1p=4.2 mM
−1 s−1) 
to 3.8 (r1p=16.2 mM
−1 s−1), which again points to the formation of aggregates (Figure 6). The low relaxivity 
measured at pH 12.0 points to the absence of coordinated water molecules (q=0) at high pH values. This is 
probably related to the formation of hydroxo species and/or the coordination of carbonate anions dissolved in 
the aerated aqueous solution to the Gd
III
 ion, thereby replacing the bound water molecules.
[34] 
The lower 
negative charge of GdL
2
 compared with GdL
3
 and GdL
4
 may favors the formation of ternary adducts with 
carbonate. The 
1
H NMRD profiles obtained at pH 11.8 and 7.1 (Figure S5) clearly confirm that lowering the 
pH favors both an increase of the hydration state and the formation of aggregates in solution. Indeed, at pH 
7.1 r1p increases in the frequency range 10-70 MHz, which is characteristic of slowly tumbling substrates. 
 
 
The relaxivity increase is more pronounced that in the case of [GdL
3
], pointing to a more extended 
aggregation. 
The NMRD profile recorded at 25 °C and pH 7.1 could be fitted assuming the following parameters: q=1, 
τR
298
=290 ps, r=3.0 Å, Δ2=5×1019 s−2 and τV=27 ps (τv is the electronic correlation time for the modulation of 
the zero-field-splitting interaction and Δ2 is the mean square zero-field-splitting energy). Although these 
parameters must be taken with caution, as both global and local motions might contribute to the τR in slowly 
tumbling substrates, the values obtained from this analysis are in agreement with the formation of relatively 
small aggregates (3–4 complex units). It must be pointed out that both the tendency to oligomerize and to 
increase the q value by going from basic to neutral/acidic conditions have been previously observed and 
reported in the case of other Gd
III
 phosphonate complexes.
[35]
 
The GdL
4
 complex forms a monomeric species in solution with a well-defined hydration number (q=1) at 
about neutral pH. Thus, we have carried out a more detailed study of the parameters that govern the observed 
relaxivity. 
1
H NMRD profiles of GdL
4
 were measured at 10, 25 and 37 °C in the proton Larmor frequency 
range 0.01–70 MHz at pH 7.4 (Figure 8). 
The relaxivity of GdL
4
 decreases with increasing temperature over the entire range of proton Larmor 
frequency investigated, showing that the relaxivity is limited by the fast rotation of the complex in solution 
rather than by a slow water exchange rate. Furthermore, we have measured reduced transverse 
17
O relaxation 
rates (1/T2r) and reduced 
17
O NMR chemical shifts (Δωr) to obtain information on the exchange rate of the 
coordinated water molecule (Figure 8).The sign of the temperature dependence of 1/T2r depends on whether 
the transverse relaxation is dominated by τM, which decreases with increasing temperature, or by the 
relaxation time of the bound water molecule, T2m, which normally increases with increasing temperature. For 
GdL
4
, 1/T2r decreases upon increasing temperature in the temperature range 352–274 K, which is typical of 
systems in the fast exchange regime (kex
298
 > ca. 10
7
 s
−1
). 
It has been demonstrated that phosphonate and phosphinate groups induce the formation of a second-sphere 
hydration shell around Gd
III
 complexes due to their high negative charge.
[11a,36] 
Second-sphere water 
molecules remain a non-negligible time in the proximity of the Gd
III
 ion, thereby providing a significant 
contribution to the observed proton relaxivity. 
The second-sphere term also contributes to the longitudinal 
17
O NMR relaxation, which is influenced by the 
dipolar and quadrupolar contributions, but not to the transverse 
17
O NMR relaxation and chemical 
shifts.
[37, 38] 
Thus, a second-sphere contribution was taken into account only for the analysis of the 
1
H NMRD 
data of GdL
4
. A simultaneous fitting of the 
1
H NMRD and 
17
O NMR data was performed by using the 
Solomon-Bloembergen-Morgan theory to describe the inner- and second-sphere contributions to 
relaxivity,
[39] 
the Freed model equations to account for the outer-sphere contribution to relaxivity,
[40] 
and the 
Swift–Connick equations to represent the temperature dependence of 17O transverse relaxation rates and 
chemical shifts.
[41]
 The following parameters have been fixed during the fitting procedure: the number of 
water molecules in the inner coordination sphere of Gd
III
 was fixed to q=1 on the basis of luminescence 
lifetime measurements; the distance between the proton nuclei of the coordinated water molecule and the 
Gd
III
 ion (rGdH) was fixed at 3.0 Å,
[42] 
while the distance of closest approach for the outer-sphere 
contribution, aGdH, was set to 4.0 Å; the distance of second-sphere water protons and the Gd
III
 ion was fixed 
at 3.60 Å,
[38] 
while the number of second-sphere water molecules was taken as q
2nd
=4 and the residence time 
of these water molecules in the second hydration shell was set to 1 ns;
[43] 
the values of the diffusion 
coefficient (DGdH
298
) and its activation energy (ED) were fixed at the common values of 2.24×10
−5
 cm
2 s−1 and 
21 kJ mol−1, respectively.[44] Finally, the activation energies for the rotational correlation time, ER, and the 
activation energy for the modulation of the zero-field-splitting (EV) were fixed to typical values (18 and 1 
kJ mol−1, respectively). An excellent fit of the 1H NMRD and 17O NMR data was obtained with the 
 
 
parameters listed in Table 3, which also shows data reported previously for related non-macrocyclic systems 
containing phosphonate groups (see Scheme 3). 
The sum of the outer-sphere and second-sphere contributions to relaxivity obtained from the fit of the 
NMRD and 
17
O NMR data assumes the value of 4.9 mM
−1 s−1 (298 K, 20 MHz). This value is quite 
comparable to the relaxivity observed for GdEGT4P (5.3 mM
−1 s−1), which contains four phosphonate groups 
but lacks any coordinated water molecule (the observed relaxivity is therefore the result of the outer-sphere 
and second-sphere mechanisms). The value of τR
298
 (121 ps) is in the range expected for a complex with low 
molecular weight, being very close to that reported for the complex of BCPE2P. The value obtained for the 
hyperfine coupling constant (A/ħ) falls within the range reported for GdIIIcomplexes, which confirms the 
presence of one water molecule in the inner-sphere coordination shell of Gd
III
.
[45]
 
 
 
Figure 8. 
1
H NMRD profiles (top) and reduced transverse 
17
O relaxation rates (triangles) and 
17
O chemical shifts 
(circles, bottom, 11.74 T) measured for GdL
4
 at pH 7.4. The lines represent the fit of the data (see text). 
 
 
 
Figure 9. 
1
H NMRD profile measured for GdL
4
 at pH 7.4 and 37 °C and the contributions of the inner-sphere, second-
sphere and outer-sphere mechanisms obtained from the analysis of the data. The line through the experimental data 
points represents the fit of the data as described in the text. 
 
 
 
Scheme 3. Ligands used for the comparison of relaxivity properties. 
 
The parameters describing electron spin relaxation (Δ2 and τV) are also close to those determined for related 
systems (Table 3). The exchange rate of the inner-sphere water molecule is very high when compared to 
those of [Gd(DTPA)]
2−
 and [Gd(DOTA)]
−
 (kex
298
=3.3×10
6
 and 4.1×10
6
 s
−1
, respectively),
[44]
 and about 15 
times faster than that reported for the complex of the carboxylate derivative Py (Scheme 2). This is in line 
with previous observations, which showed that the replacement of acetate groups by phosphonate units 
results in a marked acceleration of the exchange rate of inner-sphere water molecules.
[48]
 
 
 
As stated before, a number of assumptions had to be made to account for the second-sphere contribution to 
relaxivity. Thus, the contributions calculated for the inner- second- and outer-sphere mechanisms from the 
analysis of the NMRD profiles have to be taken with some caution. In spite of this, our analysis suggests that 
the contribution of the second-sphere mechanism to the overall relaxivity at physiological temperature is 
quite important (Figure 9). At low fields (0.01–10 Hz) this contribution is clearly higher than that of the 
outer-sphere, while at higher fields the second- and outer-sphere mechanisms provide comparable 
contributions to the overall relaxivity. 
 
Table 3. Parameters obtained from the simultaneous analysis of 
1
H NMRD profiles and 
17
O NMR data (11.74 T)  
for the Gd
III
 complex of L
4
 and the related ligands. 
 
Parameter L
4
 EGT4P
[b]
 BCPE2P
[c]
 DTTAP
[d]
 Py
[e]
 
20
r1
298
 [mM
−1 s−1] 8.4 5.3 4.9 6.5   
Δ2×1019 [s−2] 9.2±0.5 6.2 8.2 4.5 9.6 
τV
298
 [ps] 15±1 23 22 22 2.8 
kex
298
×10
6
 [s
−1
] 142.8±0.5 / 700 11.4 9.3 
τR
298
 [ps] 121±4 / 109 86 92 
q 1
[a]
 0 0.64 1.0 2 
rGdH [Å] 3.0
[a]
 / 3.1 3.1 – 
q
2nd
 4 4 3 2.2 – 
rGdH
2nd
 [Å] 3.60 3.82 3.5 3.5 – 
EV [kJ mol
−1
] 1.0
[a]
   1.0 1.0 1.0 
ΔHM
#
 [kJ mol−1] 29.5±0.6 / 22 41 50.4 
A/ħ×106 [rad s−1] −3.5±0.2 / −3.5 −3.3 −3.7 
      
[a] Parameters fixed during the fitting procedure.  
[b] Data from reference [46].  
[c] Data from reference [37].  
[d] Data from reference [30].  
[e] Parameters obtained from the analysis of 
17
O NMR data, reference [47]. 
 
 
Mouse imaging 
Considering the excellent relaxivity properties of the Gd
III
 complex of ligand L
4
, it was of particular interest 
to check its properties in vivo. The complex was injected through the tail vein of a mice and its 
biodistribution was followed as a function of time in different regions of interest (ROI) over a period of 10 
min post-injection. The ROIs correspond to the relaxivity variations for muscles, kidneys (left and right), 
liver and vein and are presented in Figure S5. Figure 10 displays images acquired before and 120 min post 
injection, while the variations of the relaxivity in the ROI as a function of time are shown in Figure 11. 
As can be seen from Figure 11, the complex shows a rapid clearance from blood, with a signal enhancement 
of the different tissues. Contrast is, at maximum, increased by about 30 % in kidney, 25 % in vein, 10 % in 
liver and muscle. In this last tissue, the contrast decreased slowly during the 10 min of acquisition. 
Elimination is mainly observed by the kidneys. Blood clearance was unfortunately too rapid to envisage 
angiography. During the course of the experiment, it should be emphasized that the administration seemed to 
be particularly well tolerated by the animal with no movements during injection, a normal wakening, and no 
sign of a delayed intolerance (neither thirsty, nor behavioral abnormalities). 
 
 
 
 
Figure 10. Different slices of a mouse MRI imaging observed before (a) and 120 min (b) post-injection of 200 μL of a 
GdL
4
 solution at 200 μL min−1 (0.02 mmol Gd per kg). 
 
 
 
Figure 11. Relaxivity variations observed in the regions of interest during the biodistribution experiment. 
 
 
Conclusion 
Pyridyl-based phosphonated chelates represent very promising platforms for the complexation of lanthanide 
cations. In particular, the complexes obtained with the tetraphosphonated ligand L
4
 forms complexes with an 
extremely high thermodynamic stability. Nevertheless, the presence of numerous phosphonate functions is 
also accompanied by important secondary interactions, probably related to hydrogen-bonding interactions, 
especially in acidic media. For the Gd
III
 complexes studied here, these interactions are translated into 
important contributions of the second and outer sphere mechanisms to the overall relaxivity of the 
compounds. Additionally, the decrease of the pH led to the formation of aggregates which severely impacts 
the rotational correlation times and led to further increase of the relaxivity. MRI imaging on mice showed the 
GdL
4
 complex to be well suited for contrast enhancement, while small modifications on the ligand backbone 
such as para-functionalisation of the central pyridine ring
[49]
 may allow an increase of the retention time in 
the bloodstream. Finally, although yet only superficially understood, the formation of these aggregates or 
polymeric species may correspond to discrete entities, as suggested by the results of the UV/Vis titration 
experiments (Figure 1 and S1) and as observed for other phosphonated
[50]
 and carboxylated
[51]
 ligands. 
Current efforts are directed towards the understanding of these Ln
III
 based supramolecular assemblies 
through mixtures of different luminescent lanthanide complexes and the study of Ln
III
 to Ln
III
 energy transfer 
phenomena.
[52]
 
 
Experimental Section 
Ligands L
2
 to L
4
 were synthesized according to previously published procedure.
[18]
 
Potentiometric titrations: Full experimental details can be found in the supplementary information section. 
Spectroscopy: UV/Vis absorption spectra were recorded on a Specord 205 (Analytik Jena) or a Perkin–Elmer 
lambda 950 spectrometer. Steady-state luminescence emission and excitation spectra were recorded on a 
Horiba Jobin Yvon Fluorolog 3 spectrometer working with a continuous 450 W Xe lamp. Detection was 
performed with a Hamamatsu R928 photomultiplier. All spectra were corrected for the instrumental 
response. When necessary, a 399 nm cut off filter was used to eliminate the second order artefacts. 
Phosphorescence decays were measured on the same instrument working in the phosphorescence mode, with 
50 μs delay time and a 100 ms integration window or working in the Time Correlated Single Photon 
Counting (TCSPC) Lifetime Spectroscopy mode, both using a Xenon flash lamp as the excitation source. 
Monoexponential decay profiles were fitted with the FAST program from Edinburgh Instruments or with the 
Data station software from Jobin Yvon. Luminescence quantum yields were measured according to 
conventional procedures, with optically diluted solutions (optical density <0.05), using rhodamine 6G in 
water (ϕ=76.0 %)[53] or a TbIII complex of the literature (ϕ=31.0 %)[54] as references for TbIII and 
[Ru(bipy)3]Cl2 in water (ϕ=4.0 %)
[55] 
for Eu
III. Estimated errors are ±15 %. 
NMR measurements: 
1
H, 
13
C and 
31
P NMR spectra were recorded in D2O on a Bruker Avance 300 MHz 
spectrometer operating at 300.13 (
1
H), 75.47 (
13
C) and 121.49 MHz (
31
P). Spectral assignments were based 
in part on two-dimensional COSY, NOESY, HMQC, and HMBC experiments. 
1
H, 
13
C NMR spectra 
recorded in D2O solution were referenced by using tert-butyl alcohol as an internal standard with the methyl 
signal calibrated at δ=1.2 (1H) and 31.2 ppm (13C). 31P NMR chemical shifts were reported in ppm relative to 
external H3PO4 (85 %). Samples of the complexes for NMR measurements were prepared by dissolving 
equimolar amounts of the ligand and hydrated LnCl3 in D2O, followed by adjustment of the pH with ND4OD 
and DCl (Aldrich) solutions in D2O. Values of pD are corrected for deuterium isotopic effect (pD=pHreading + 
0.4).
[56]
 
 
 
The water proton longitudinal relaxation rates as a function of temperature (20 MHz) were measured with a 
StelarRelaxometer (Mede, PV, Italy) on about 0.6–2.0 mM aqueous solutions in non-deuterated water. The 
exact Gd
III
 concentrations were determined by measurement of bulk magnetic susceptibility shifts of 
a tBuOH signal on a Bruker Avance III spectrometer (11.74 T).
[57]
 The 
1
H T1 relaxation times were acquired 
by the standard inversion recovery method with typical 90° pulse width of 3.5 μs, 16 experiments of 4 scans. 
The reproducibility of the T1 data was ±5 %. The temperature was controlled with a Stelar VTC-91 airflow 
heater equipped with a calibrated copper-constantan thermocouple (uncertainty of ±0.1 °C). The proton 
1/T1 NMRD profiles were measured on a fast field-cycling Stelar Smart Tracer relaxometer over a 
continuum of magnetic field strengths from 0.00024–0.25 T (corresponding to 0.01–10 MHz proton Larmor 
frequencies). The relaxometer operates under computer control with an absolute uncertainty in 1/T1 of ±1 %. 
Additional data points in the range 15–70 MHz were obtained on a Stelar Relaxometer equipped with a 
Bruker WP80 NMR electromagnet adapted to variable-field measurements (15–80 MHz proton Larmor 
frequency).
17
O NMR measurements were recorded on a Bruker Avance III spectrometer (11.74 T) equipped 
with a 5 mm probe and standard temperature control unit. A 12.3 mM aqueous solution of GdL
4
 containing 
1.0 % of the 17O isotope (CortecNet, Paris) was used. The observed transverse relaxation rates were 
calculated from the signal width at half-height. 
DFT calculations: All calculations were performed employing hybrid DFT with the B3LYP exchange-
correlation functional,
[58, 59] 
and the Gaussian 09 package (Revision B.01).
[60]
 Full geometry optimizations of 
the [LuL
4
]
5−
 systems were performed in aqueous solution by using the large-core effective core potential 
(LCECP) of Dolg et al. and the related [5s4p3d]-GTO valence basis set for the lanthanides,
[61]
 and the 6-
31G(d) basis set for C, H, N, O and P atoms. No symmetry constraints have been imposed during the 
optimizations. The default values for the integration grid (“fine”) and the SCF energy convergence criteria 
(10
−8
) were used. The stationary points found on the potential energy surfaces as a result of the geometry 
optimizations were checked to correspond to energy minima rather than saddle points using frequency 
analysis. Solvent effects were evaluated by using the integral equation formalism of the polarizable 
continuum model (IEFPCM), as implemented in Gaussian 09.
[62]
 
The relative free energies of the different conformations obtained from geometry optimizations were 
calculated in aqueous solution at the B3LYP/LCECP/6-31G(d) level, including non-potential-energy 
contributions (zero point energies and thermal terms) obtained through frequency analysis. The Δ(δλδλ) ↔ 
Δ(δδδδ) and Δ(δλδλ) ↔ Λ(δλδλ) interconversion processes were investigated using the synchronous transit-
guided quasi-Newton method.
[63]
 The nature of the saddle points was characterized by frequency analysis 
(one imaginary frequency). Examination of the normal mode corresponding to the imaginary frequency 
confirmed that the corresponding transition state connects the reactant and product of interest. In the case of 
the Δ(δλδλ) ↔ Λ(δλδλ) interconversion processes this was further confirmed by following the reaction path 
by integrating the intrinsic reaction coordinate (IRC).
[64] 
The calculated free energy barriers include non-
potential energy contributions obtained by frequency analysis. 
NMR shielding tensors were calculated in aqueous solution by using the GIAO
[65]
 method and the more 
extended 6-311G(d,p) basis set for the ligand atoms. The calculated absolute chemical shielding values (σiso) 
were converted to chemical shifts (δ) relative to 85 % H3PO4 by comparison to the chemical shielding of 
PH3 at the same level of theory.
[66]
 
 
 𝛿calcd([Lu𝐋𝟒]5−) = 𝜎calcd(PH3) − 𝜎calcd([Lu𝐋𝟒]5−) − 266.1 
 
 
 
Mouse imaging: Mice whole body MR images were acquired at 1.5 T, using a preclinical MRI device 
(OPTImouse, RS2D, France), inside a volume RF coil (RapidBiomedical, Germany) of 40 mm in diameter. 
Intravenous administration of the contrast agent was performed via a catheter in a tail vein of the mice (three 
animals, mean weight 25 g), connected to an infusion pump (PHD 2000, Harvard Apparatus, USA) at a 
speed of 200 μL min−1 (total volume of 200 μL, including 100 μL of contrast agent at 5 mM, corresponding 
to a Gd dose of 0.02 mmol kg−1 per body weight). Mice were kept under anaesthesia (Isoflurane + air) and 
warmed to maintain homeostasis, throughout acquisition, in an imaging cell (Minerve, France). 2D dynamic 
acquisition (1 slice of 1.25 mm thickness) involves 100 images every 6 s for a total acquisition time of 10 
min. Acquisition was started about 30 s before contrast agent injection beginning. Regions of interest (ROI) 
were drawn in Osirix (http://www.osirix-viewer.com/), encompassing part of liver, kidney, muscle and 
inferior vena cava. Mean values of signal inside these ROI were computed for all images leading to time-
signal curves. 
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